The Portuguese Competition Authority imposes fines to 5 pharmaceutical companies for collusion in tender procedures for the provision of medical supplies to public hospitals (Abbott, Bayer, Johnson & Johnson...)

In January 2005 the Portuguese Autoridade da Concorrência (hereinafter, the “NCA”) imposed a € 658,413.22 fine on five pharmaceutical companies involved in collusive practices in a public tender procedure for the purchase by the Centro Hospitalar de Coimbra (“CHC”) of 4,000 packages of chemically reactive strips (see P. Pablo Ibáñez Colomo, “The Portuguese competition authority adopts a decision against five pharmaceutical companies pursuant to Article 4(1) of the Competition Act of 2003 for collusion in a public tender procedure”, e-Competitions,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Pablo Ibáñez Colomo, The Portuguese Competition Authority imposes fines to 5 pharmaceutical companies for collusion in tender procedures for the provision of medical supplies to public hospitals (Abbott, Bayer, Johnson & Johnson...), 13 October 2005, e-Competitions October 2005, Art. N° 319

Visites 3255

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues